Anne-Marie Van Dam Selected Research

Anne-Marie Van Dam Research Topics

Disease

5	Inflammation (Inflammations) 01/2021 - 06/2002
5	Multiple Sclerosis 11/2015 - 04/2005
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2005
2	Pain (Aches) 01/2022 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2021 - 05/2015
2	Hyperalgesia 01/2021 - 05/2015
2	Neuroinflammatory Diseases 01/2021 - 08/2007
2	Brain Diseases (Brain Disorder) 01/2021 - 05/2015
1	Memory Disorders (Memory Loss) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 03/2020
1	Ataxia (Dyssynergia) 03/2020
1	Atrophy 03/2020
1	Gliosis 03/2020
1	Nervous System Diseases (Neurological Disorders) 03/2020
1	Paralysis (Palsy) 05/2015
1	Encephalomyelitis (Myeloencephalitis) 08/2014
1	Demyelinating Diseases (Demyelinating Disease) 01/2013
1	Neuroblastoma 06/2011
1	Parkinson Disease (Parkinson's Disease) 06/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2007
1	Infections 01/2007
1	Necrosis 01/2007
1	Dementia (Dementias) 01/2007
1	Bacterial Meningitis 01/2007
1	Brain Ischemia (Cerebral Ischemia) 07/2004
1	Stroke (Strokes) 07/2004
1	Fever (Fevers) 06/2002

Drug/Important Bio-Agent (IBA)

4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 07/2004
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 04/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
2	Protein Glutamine gamma Glutamyltransferase 2IBA 11/2015 - 06/2011
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013 - 07/2004
2	CytokinesIBA 01/2007 - 06/2002
2	ChemokinesIBA 01/2007 - 04/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 09/2005
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2005 - 06/2002
1	Neutralizing AntibodiesIBA 01/2022
1	NLR ProteinsIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Naltrexone (ReVia)FDA LinkGeneric 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Glutens (Glutelin)IBA 03/2020
1	Multifunctional EnzymesIBA 11/2015
1	Adenosine (Adenocard)FDA LinkGeneric 05/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2014
1	IonophoresIBA 06/2011
1	EnzymesIBA 06/2011
1	AminesIBA 06/2011
1	SynucleinsIBA 06/2011
1	Calcimycin (A23187)IBA 06/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2007
1	Interleukin-6 (Interleukin 6)IBA 09/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2005
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2005
1	G-Protein-Coupled Receptor Kinase 2IBA 04/2005
1	NeuropeptidesIBA 04/2005
1	Neuroprotective AgentsIBA 07/2004
1	LipopolysaccharidesIBA 06/2002
1	InterleukinsIBA 06/2002
1	Interleukin-10 (Interleukin 10)IBA 06/2002

Therapy/Procedure

1	Spinal Injections 01/2022
1	Therapeutics 01/2021
1	Intraventricular Infusions 06/2002